Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
17.87
+0.07 (0.39%)
May 13, 2025, 2:45 PM CST
SHA:688062 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | -1,130 | -1,044 | -1,053 | -955.23 | -769.59 | -642.55 | Upgrade
|
Depreciation & Amortization | 129.21 | 129.21 | 104.31 | 89.29 | 80.46 | 56.39 | Upgrade
|
Other Amortization | 17.01 | 17.01 | 5.14 | 6.58 | 6.82 | 6.57 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | 0 | -0.33 | -2.06 | 0.01 | Upgrade
|
Asset Writedown & Restructuring Costs | 0.11 | 0.11 | 3.56 | 0.02 | - | 1.94 | Upgrade
|
Loss (Gain) From Sale of Investments | 4.07 | 4.07 | 1.25 | -1.8 | -3.85 | -15.52 | Upgrade
|
Provision & Write-off of Bad Debts | 0.03 | 0.03 | 0.03 | -0.01 | -0.03 | 1.7 | Upgrade
|
Other Operating Activities | 256.47 | 56.42 | 16.76 | 9.07 | 2.48 | -0.6 | Upgrade
|
Change in Accounts Receivable | -77.36 | -77.36 | -42.88 | 15.21 | -24.01 | -12.72 | Upgrade
|
Change in Inventory | -57.91 | -57.91 | -86.18 | -40.88 | -7.73 | -9.94 | Upgrade
|
Change in Accounts Payable | -36.24 | -36.24 | 149.89 | 6.57 | 109.33 | 20.39 | Upgrade
|
Change in Other Net Operating Assets | 28.82 | 28.82 | 118.2 | 152.33 | 185.77 | 79.33 | Upgrade
|
Operating Cash Flow | -842.46 | -956.44 | -782.73 | -719.17 | -422.4 | -514.99 | Upgrade
|
Capital Expenditures | -266.56 | -330.07 | -499.91 | -544.96 | -217.51 | -130.62 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | 0 | 0.01 | - | - | Upgrade
|
Cash Acquisitions | -7.3 | - | -24 | - | - | - | Upgrade
|
Divestitures | - | - | - | - | - | -0.05 | Upgrade
|
Investment in Securities | 100.1 | 35.53 | -12.28 | -60 | 225.41 | -239.25 | Upgrade
|
Other Investing Activities | 3.02 | 2.99 | 26.57 | 2.15 | 4.94 | 12.7 | Upgrade
|
Investing Cash Flow | -170.74 | -291.55 | -509.62 | -602.8 | 12.84 | -357.22 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | - | 64 | Upgrade
|
Long-Term Debt Issued | - | 3,605 | 605.3 | 460.07 | 142.87 | 50.04 | Upgrade
|
Total Debt Issued | 2,897 | 3,605 | 605.3 | 460.07 | 142.87 | 114.04 | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | - | -237.5 | Upgrade
|
Long-Term Debt Repaid | - | -2,705 | -133.06 | -37.91 | -69.09 | - | Upgrade
|
Total Debt Repaid | -2,488 | -2,705 | -133.06 | -37.91 | -69.09 | -237.5 | Upgrade
|
Net Debt Issued (Repaid) | 408.88 | 900.38 | 472.23 | 422.17 | 73.78 | -123.46 | Upgrade
|
Issuance of Common Stock | - | - | - | 3,323 | 125.95 | 1,280 | Upgrade
|
Common Dividends Paid | -74.35 | -66.11 | -34.1 | -13.12 | -0.79 | - | Upgrade
|
Other Financing Activities | 93.86 | -2.57 | 6.8 | -16.1 | - | -1.04 | Upgrade
|
Financing Cash Flow | 428.39 | 831.7 | 444.94 | 3,716 | 198.94 | 1,155 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.08 | 0.23 | 1.4 | 2.26 | -1.01 | -1.72 | Upgrade
|
Net Cash Flow | -584.74 | -416.07 | -846.01 | 2,396 | -211.63 | 281.25 | Upgrade
|
Free Cash Flow | -1,109 | -1,287 | -1,283 | -1,264 | -639.91 | -645.61 | Upgrade
|
Free Cash Flow Margin | -626.51% | -643.96% | -1003.35% | -4559.01% | -3943.69% | -12176.27% | Upgrade
|
Free Cash Flow Per Share | -2.78 | -3.22 | -3.21 | -3.23 | -2.14 | -2.27 | Upgrade
|
Cash Interest Paid | - | - | - | - | - | 1.04 | Upgrade
|
Cash Income Tax Paid | 19.89 | 20.98 | -69.09 | -141.94 | 0.99 | 0.89 | Upgrade
|
Levered Free Cash Flow | -788.87 | -1,063 | -824.71 | -925.61 | -354.48 | -608.18 | Upgrade
|
Unlevered Free Cash Flow | -748.69 | -1,027 | -816.37 | -919.18 | -350.47 | -607.53 | Upgrade
|
Change in Net Working Capital | -28.38 | 229.98 | -135.53 | -4.07 | -94.88 | 201.6 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.